🇺🇸 FDA
Patent

US 9757468

Intranasal administration of guanidinylated aminoglycosides

granted A61KA61K38/46A61K38/47

Quick answer

US patent 9757468 (Intranasal administration of guanidinylated aminoglycosides) held by The Regents of the University of California expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/46, A61K38/47, A61K39/39533, A61K47/549